Not finding it? Sign in to also search OpenAlex live.
-
LBP1 Interim results of an open-label, multicentre, Phase 1/2 study to assess YTB323 (rapcabtagene autoleucel), a CAR T-cell therapy, for severe refractory systemic lupus erythematosus
Josefina Cortés Hernández, Pere Barba, Mi Kwon, Julia Weinmann‐Menke, Eva Wagner-Drouet, O. Fischer, +9 more
3citations
2 results